tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CK Life Sciences Issues Profit Warning Amid Increased R&D Investments

Story Highlights
  • CK Life Sciences expects a HK$150 million loss in H1 2025 due to increased R&D investments.
  • The company’s operations remained stable despite the anticipated financial loss.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
CK Life Sciences Issues Profit Warning Amid Increased R&D Investments

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

CK Life Sciences International (Holdings), Inc. ( (HK:0775) ) has provided an update.

CK Life Sciences International (Holdings) Inc. has issued a profit warning, indicating an expected loss of approximately HK$150 million for the first half of 2025, compared to a HK$1 million profit in the same period in 2024. This shift from profit to loss is primarily due to the company’s strategic decision to increase investments in research and development, while the overall operations remained stable. The final financial results are still being finalized and will be disclosed in the interim results announcement on 12 August 2025.

More about CK Life Sciences International (Holdings), Inc.

CK Life Sciences International (Holdings) Inc. operates in the biotechnology industry, focusing on research and development in life sciences. The company is engaged in producing pharmaceuticals, nutraceuticals, and agriculture-related products, with a market focus on advancing health and environmental sustainability.

Average Trading Volume: 9,385,691

Technical Sentiment Signal: Buy

Current Market Cap: HK$9.61B

For an in-depth examination of 0775 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1